Biological E to start phase-III trials by January, license vaccine by summer
Posted by
www.biotecnika.org
Disclosing this in Hyderabad on Monday, managing director Mahima Datla
said the company is currently evaluating four different formulations
depending on different antigen strengths in the phase I-II combined
studies.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/biological-e-to-start-phase-iii-trials-by-january-license-vaccine-by-summer/articleshow/79382405.cms
Subscribe to:
Post Comments (Atom)
Post a Comment